Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings

Quest Diagnostics just posted Q3 2026 results that looked firm on paper while the stock barely flinched. Shares sit at about US$241.89, down 0.6% today and only modestly higher over the past month, even as revenue for the quarter reached roughly US$3.1b and adjusted earnings per share landed near US$3.00. That muted price move appears to reflect investor caution rather than the quality of this report. The market seems to be treating a solid earnings print and raised full year guidance as...